| Stay updated on the top DIGITAL HEALTH NEWS |
|---|
|
|
NHS Herefordshire and Worcestershire Drives Innovation with Surgery Connect
- Details
- Category: Industry
One of England's integrated care systems proved the benefit of modern, cloud-telephony during the COVID-19 pandemic, and is now working with X-on on new ideas to support GPs and patients, following a roll-out to practices. Associate director of digital & technology Alicia Dunsby explains.
Philips Recognized as Top Innovator for 10th Consecutive Year
- Details
- Category: Philips
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has once again been recognized as a Clarivate Top 100 Global Innovator™ in Clarivate Analytics' 2023 list, which measures excellence focused on consistency and scale in innovativeness [1], thanks to its constant high performance on these metrics. Philips has now been included in this reputable list for 10 consecutive years.
Why Marketing Matters for Health Tech Start-Ups and Scale-Ups
- Details
- Category: Opinion
You've got an innovative and excellent product, so why aren't NHS influencers and decision makers talking about it? Simple answer may be that they don’t know about you, your product or its value. Effective marketing can help you to change this.
How could a New Urgency to Modernise Clinical Audit Help in the NHS?
- Details
- Category: Opinion
NHS teams are under pressure. Could modern digital approaches to clinical audit be a quick win to help relieve just some of the burden? Could organisations better understand performance at such busy times? And could compliance with new CQUINs be supported in the process?
Open Call HORIZON-HLTH-2023-DISEASE-03-06: Towards Structuring Brain Health Research in Europe
- Details
- Category: Open Calls
This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination 3 "Tackling diseases and reducing disease burden". To that end, proposals under this topic should aim for delivering results that are directed, tailored towards and contributing to most of the following expected outcomes:
What's Your Gut Telling You?
- Details
- Category: Research
In a study published in Nature Electronics, Khalil B. Ramadi, Assistant Professor of Bioengineering at NYU Tandon School of Engineering, revealed that he and a team of collaborators at MIT and Caltech have developed a tiny pill-like electromagnetic device that,
Ride The Digital Transformation Wave with AUTOMA+ Healthcare 2023
- Details
- Category: Events
25 - 26 September 2023, Zurich, Switzerland.Healthcare Automation and Digitalization Congress 2023 is held on September, 25-26, 2023, in Zurich, Switzerland. AUTOMA+ 2023 gathers leaders and digital experts from hospitals, healthcare providers and pharmaceutical companies with the main aim to drive the healthcare industry towards successful digital transformation.
HUS Helsinki University Hospital is Leading the Research Project on Long-Term Effects of COVID-19
- Details
- Category: Development
The EU has awarded a 6.55 million EUR funding to a HUS Helsinki University Hospital-led consortium to examine the mechanisms behind the long-term effects of a COVID-19 infection. The objective is also to create a Decision support system for prediction and management of Long Covid Syndrome (LCS).
Philips and TriHealth Announce Multi-Year Partnership at Heart of New TriHealth Heart & Vascular Institute on the Campus of Bethesda North Hospital
- Details
- Category: Philips
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, has entered into a long-term strategic partnership with TriHealth, a leading Cincinnati-based integrated healthcare delivery system, to adopt Philips' integrated portfolio of cardiology solutions for its new TriHealth Heart & Vascular Institute on the campus of Bethesda North Hospital and the Harold and Eugenia Thomas Comprehensive Care Center.
Insilico Medicine Receives FDA Orphan Drug Designation for Generative AI Discovered and Designed Drug for Idiopathic Pulmonary Fibrosis
- Details
- Category: Industry
Insilico Medicine ("Insilico"), a clinical-stage end-to-end generative artificial intelligence (AI)-driven drug discovery company, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to INS018_055 for the treatment of Idiopathic Pulmonary Fibrosis (IPF).